10
Participants
Start Date
October 31, 2012
Primary Completion Date
October 31, 2013
Study Completion Date
March 31, 2015
Extracorporeal photopheresis
Extracorporeal photopheresis with Methoxsalen(UVADEX)and immunosuppression reduction Extracorporeal photopheresis (ECP) is an immunomodulatory excellent technical tolerated initially designed for the treatment of cutaneous T-cell lymphoma and various autoimmune diseases, which has been proven effective in reversing episodes acute heart transplants, kidney and lung rejection, and in the treatment of Disease graft versus host both acute and chronic.
Jose Antonio Pons, MD, Murcia
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
OTHER